{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:44:29Z","timestamp":1759538669349,"version":"build-2065373602"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01GM100784"],"award-info":[{"award-number":["R01GM100784"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.tox.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T14:30:23Z","timestamp":1472135423000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immunogenicity of trimethoprim\/sulfamethoxazole in a macaque model of HIV infection"],"prefix":"10.1016","volume":"368-369","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2452-1460","authenticated-orcid":false,"given":"Yat Yee","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8197-5309","authenticated-orcid":false,"given":"Eva G.","family":"Rakasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Gasper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-6895","authenticated-orcid":false,"given":"Thomas C.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A.","family":"Trepanier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2016.08.010_bib0005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2125.2010.03889.x","article-title":"Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis","volume":"71","author":"Abouraya","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2016.08.010_bib0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/0091270010393343","article-title":"Dapsone-associated methemoglobinemia in a patient with slow NAT2*5b haplotype and impaired cytochrome b5 reductase activity","volume":"52","author":"Abouraya","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2016.08.010_bib0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.tibtech.2007.05.004","article-title":"HIV\/AIDS: in search of an animal model","volume":"25","author":"Ambrose","year":"2007","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.tox.2016.08.010_bib0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00204-010-0530-z","article-title":"Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine","volume":"84","author":"Bhusari","year":"2010","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2016.08.010_bib0025","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.tox.2016.08.010_bib0030","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjp.0703845","article-title":"Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells","volume":"132","author":"Burkhart","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2016.08.010_bib0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/infdis\/167.1.180","article-title":"Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS","volume":"167","author":"Carr","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tox.2016.08.010_bib0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00002030-199403000-00006","article-title":"Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients","volume":"8","author":"Carr","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.tox.2016.08.010_bib0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/clinids\/18.3.319","article-title":"Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia","volume":"18","author":"Caumes","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tox.2016.08.010_bib0050","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1124\/mol.107.043273","article-title":"Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo","volume":"73","author":"Cheng","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2016.08.010_bib0055","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/FPC.0000000000000124","article-title":"HLA-allelotype associations with nevirapine-induced hypersensitivity reactions and hepatotoxicity: a systematic review of the literature and meta-analysis","volume":"25","author":"Cornejo Castro","year":"2015","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.tox.2016.08.010_bib0060","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0090-9556(25)08967-6","article-title":"Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione: implications for idiosyncratic toxicity","volume":"19","author":"Cribb","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2016.08.010_bib0065","first-page":"9","article-title":"Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis","volume":"15","author":"Cribb","year":"1996","journal-title":"Adverse Drug React. Toxicol. Rev."},{"key":"10.1016\/j.tox.2016.08.010_bib0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/aid.1992.8.387","article-title":"A comparison of regulatory features in primate lentiviruses","volume":"8","author":"Cullen","year":"1992","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.tox.2016.08.010_bib0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/cdli.2.2.199-204.1995","article-title":"Immune response to sulfamethoxazole in patients with AIDS","volume":"2","author":"Daftarian","year":"1995","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.tox.2016.08.010_bib0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mjd.2002.120468","article-title":"Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS","volume":"47","author":"Eliaszewicz","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tox.2016.08.010_bib0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.103.050112","article-title":"Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans","volume":"306","author":"Farrell","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.08.010_bib0090","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1182\/blood-2014-03-563742","article-title":"HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies","volume":"124","author":"Fernandez","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.tox.2016.08.010_bib0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jnci\/88.5.259","article-title":"Reductase enzyme expression across the nci tumor cell line panel: correlation with sensitivity to mitomycin c and EO9","volume":"88","author":"Fitzsimmons","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tox.2016.08.010_bib0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-3565(24)36867-3","article-title":"The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat","volume":"282","author":"Gill","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.08.010_bib0105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-100-4-495","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole in patients with AIDS","volume":"100","author":"Gordin","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tox.2016.08.010_bib0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0091-6749(98)70250-7","article-title":"Sulfonamide-induced reactions in desensitized patients with AIDS- the role of covalent protein haptenation by sulfamethoxazole","volume":"101","author":"Gruchalla","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tox.2016.08.010_bib0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF02599836","article-title":"Predicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary Pneumocystis carinii pneumonia prophylaxis","volume":"10","author":"Hennessy","year":"1995","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.tox.2016.08.010_bib0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00251-007-0233-7","article-title":"Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ Tcell epitopes","volume":"59","author":"Kaizu","year":"2007","journal-title":"Immunogenetics"},{"key":"10.1016\/j.tox.2016.08.010_bib0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0091-6749(94)90202-X","article-title":"Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions","volume":"94","author":"Kalish","year":"1994","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tox.2016.08.010_bib0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0009-9236(96)90168-X","article-title":"N-aceyltransferase 2 polymorphism in patients infected with human immunodeficiency virus","volume":"60","author":"Kaufmann","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2016.08.010_bib0135","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/infdis\/168.2.314","article-title":"Crossover of HIV-infected patients from aerosolizd pentamidine to trimethoprim-sulfamethoxazole: lack of hematologic toxicity and relationship of side effects to CD4+ lymphocyte count","volume":"168","author":"Kennedy","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tox.2016.08.010_bib0140","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1124\/jpet.104.072389","article-title":"NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans","volume":"311","author":"Kurian","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.08.010_bib0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.med.58.082405.094316","article-title":"Current concepts in AIDS pathogenesis: insights from the SIV\/macaque model","volume":"58","author":"Lackner","year":"2007","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.tox.2016.08.010_bib0150","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2222.2006.02506.x","article-title":"Association of drug-serum protein adducts and anti-drug antibodies in dogs with sulphonamide hypersensitivity: a naturally occurring model of idiosyncratic drug toxicity","volume":"36","author":"Lavergne","year":"2006","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.tox.2016.08.010_bib0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tox.2006.01.018","article-title":"Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso","volume":"222","author":"Lavergne","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2016.08.010_bib0160","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/jpet.109.155374","article-title":"Danger conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells","volume":"331","author":"Lavergne","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.08.010_bib0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/clpt.1993.66","article-title":"Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome","volume":"53","author":"l","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2016.08.010_bib0170","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/clpt.1994.122","article-title":"The hydroxylamine of sulfamethoxazole and adverse reactions in patients with acquired immunodeficiency syndrome","volume":"56","author":"Lee","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2016.08.010_bib0175","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1124\/mol.62.5.1011","article-title":"Haptenation of sulfonamide reactive metabolites to cellular proteins","volume":"62","author":"Manchanda","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2016.08.010_bib0180","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gut.41.4.534","article-title":"Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury","volume":"41","author":"Maria","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.tox.2016.08.010_bib0185","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1073\/pnas.88.11.4656","article-title":"Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects","volume":"88","author":"Martensson","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tox.2016.08.010_bib0190","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.155.1.462","article-title":"Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine","volume":"155","author":"Mauri-Hellweg","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2016.08.010_bib0195","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJM199009203231202","article-title":"Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome","volume":"323","author":"Medina","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2016.08.010_bib0200","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0091-6749(94)90120-1","article-title":"Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins","volume":"94","author":"Meekins","year":"1994","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tox.2016.08.010_bib0205","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1089\/088922200750054657","article-title":"Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection","volume":"16","author":"Naisbitt","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.tox.2016.08.010_bib0210","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1089\/088922200750054657","article-title":"Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection","volume":"16","author":"Naisbitt","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.tox.2016.08.010_bib0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bjp.0704074","article-title":"Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo","volume":"133","author":"Naisbitt","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2016.08.010_bib0220","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/mol.62.3.628","article-title":"Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation","volume":"62","author":"Naisbitt","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2016.08.010_bib0225","first-page":"175","article-title":"The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity","volume":"27","author":"Nyfeler","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2016.08.010_bib0230","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000235372","article-title":"Evaluation of immune parameters in HIV+ subjects reporting adverse reactions to sulfamethoxazole","volume":"94","author":"O'Neil","year":"1991","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.tox.2016.08.010_bib0235","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/00970002042006004","article-title":"Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity","volume":"42","author":"O'Neil","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2016.08.010_bib0240","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/tpj.2015.40","article-title":"Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01","volume":"16","author":"Parham","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.tox.2016.08.010_bib0245","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0753-3322(99)80101-2","article-title":"Acetylator phenotype prevalance in HIV-infected patients without previous trimethoprim-sulfamethoxazole hypersensitivity","volume":"53","author":"Quirino","year":"1999","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tox.2016.08.010_bib0250","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/003655401317074581","article-title":"Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progression","volume":"33","author":"Rabaud","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.tox.2016.08.010_bib0255","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0006-2952(97)00547-9","article-title":"Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone","volume":"55","author":"Reilly","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2016.08.010_bib0260","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/dmd.106.013680","article-title":"Formation and uptake of arylhydroxylamine-haptenated proteins in human dendritic cells","volume":"35","author":"Roychowdhury","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2016.08.010_bib0265","first-page":"23","article-title":"Sulfa hypersensitivity in patients with HIV infection Onset, treatment, critical review of the literature","volume":"97","author":"Ryan","year":"1998","journal-title":"Wis. Med. J."},{"key":"10.1016\/j.tox.2016.08.010_bib0270","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tox.2016.08.010_bib0275","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/elps.200305848","article-title":"Quantitation of reduced glutathione and cysteine in human immunodeficiency Virus-infected patients","volume":"25","author":"Sbrana","year":"2004","journal-title":"Electrophoresis"},{"key":"10.1016\/j.tox.2016.08.010_bib0280","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1046\/j.1365-2222.1998.00419.x","article-title":"T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction","volume":"28","author":"Schnyder","year":"1998","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.tox.2016.08.010_bib0285","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.4049\/jimmunol.164.12.6647","article-title":"Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ Tcells from allergic individuals","volume":"164","author":"Schnyder","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2016.08.010_bib0290","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/516993","article-title":"Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus","volume":"25","author":"Smith","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tox.2016.08.010_bib0295","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/00498250010013908","article-title":"NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes","volume":"30","author":"Trepanier","year":"2000","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2016.08.010_bib0300","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00126334-200408150-00007","article-title":"Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection","volume":"36","author":"Trepanier","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.tox.2016.08.010_bib0305","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tim.2008.08.010","article-title":"Relevance of studying T cell responses in SIV-infected rhesus macaques","volume":"16","author":"Valentine","year":"2008","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.tox.2016.08.010_bib0310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2125.1994.tb04339.x","article-title":"Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole","volume":"38","author":"VanderVen","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2016.08.010_bib0315","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00042560-199812150-00009","article-title":"A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057)","volume":"19","author":"Walmsley","year":"1998","journal-title":"J. Acquir. Immun. Def. Synd. Hum. Retrovirol."},{"key":"10.1016\/j.tox.2016.08.010_bib0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yebeh.2014.05.025","article-title":"Genetic predictors of Stevens-Johnson syndrome and toxic epidermal necrolysis induced by aromatic antiepileptic drugs among the chinese han population","volume":"37","author":"Wang","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.tox.2016.08.010_bib0325","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/vim.2010.0065","article-title":"Sustained high levels of serum interferon-gamma during HIV-1 infection: a specific trend different from other cytokines","volume":"23","author":"Watanabe","year":"2010","journal-title":"Viral Immunol."},{"key":"10.1016\/j.tox.2016.08.010_bib0330","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jana.2014.07.004","article-title":"Connecting the dots: could microbial translocation explain commonly reported symptoms in HIV disease?","volume":"25","author":"Wilson","year":"2014","journal-title":"J. Assoc. Nurses AIDS Care"},{"key":"10.1016\/j.tox.2016.08.010_bib0335","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00008571-200012000-00007","article-title":"Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in aids","volume":"10","author":"Wolkenstein","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.tox.2016.08.010_bib0340","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12016-014-8418-y","article-title":"Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review","volume":"48","author":"Yip","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16301767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16301767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:33:30Z","timestamp":1759534410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X16301767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":68,"alternative-id":["S0300483X16301767"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2016.08.010","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of trimethoprim\/sulfamethoxazole in a macaque model of HIV infection","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}